Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
The EGALITY study: a confirmatory, randomized, double‐blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate‐to‐severe chronic plaque‐type psoriasisGriffiths, C.E.M. ; Thaçi, D. ; Gerdes, S. ; Arenberger, P. ; Pulka, G. ; Kingo, K. ; Weglowska, J. ; Hattebuhr, N. ; Poetzl, J. ; Woehling, H. ; Wuerth, G. ; Afonso, M.British journal of dermatology (1951), 2017-04, Vol.176 (4), p.928-938 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
|
2 |
Material Type: Artigo
|
Histoplasmosis Complicating Tumor Necrosis Factor–α Blocker Therapy: A Retrospective Analysis of 98 CasesVergidis, Paschalis ; Avery, Robin K. ; Wheat, L. Joseph ; Dotson, Jennifer L. ; Assi, Maha A. ; Antoun, Smyrna A. ; Hamoud, Kassem A. ; Burdette, Steven D. ; Freifeld, Alison G. ; McKinsey, David S. ; Money, Mary E. ; Myint, Thein ; Andes, David R. ; Hoey, Cynthia A. ; Kaul, Daniel A. ; Dickter, Jana K. ; Liebers, David E. ; Miller, Rachel A. ; Muth, William E. ; Prakash, Vidhya ; Steiner, Frederick T. ; Walker, Randall C. ; Hage, Chadi A.Clinical infectious diseases, 2015-08, Vol.61 (3), p.409-417 [Periódico revisado por pares]United States: Oxford University PressTexto completo disponível |
|
3 |
Material Type: Artigo
|
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measuresLing, Stephanie F ; Yap, Chuan Fu ; Nair, Nisha ; Bluett, James ; Morgan, Ann W ; Isaacs, John D ; Wilson, Anthony G ; Hyrich, Kimme L ; Barton, Anne ; Plant, DarrenRheumatology (Oxford, England), 2024-04, Vol.63 (4), p.1015-1021 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
|
4 |
Material Type: Artigo
|
Etanercept biosimilar SB4 in the treatment of plaque‐type psoriasis and psoriatic arthritis: a single‐centre, observational, retrospective, real‐life studyGiunta, A. ; Manfreda, V. ; Esposito, M. ; Del Duca, E. ; Bianchi, L.British journal of dermatology (1951), 2019-11, Vol.181 (5), p.1078-1079 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
|
5 |
Material Type: Artigo
|
A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate‐to‐severe chronic plaque‐type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) studyVries, A.C.Q. ; Thio, H.B. ; Kort, W.J.A. ; Opmeer, B.C. ; Stok, H.M. ; Jong, E.M.G.J. ; Horvath, B. ; Busschbach, J.J.V. ; Nijsten, T.E.C. ; Spuls, Ph.I.British journal of dermatology (1951), 2017-03, Vol.176 (3), p.624-633 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
|
6 |
Material Type: Artigo
|
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritisEmery, Paul ; Vencovský, Jirí ; Sylwestrzak, Anna ; Leszczynski, Piotr ; Porawska, Wieslawa ; Baranauskaite, Asta ; Tseluyko, Vira ; Zhdan, Vyacheslav M ; Stasiuk, Barbara ; Milasiene, Roma ; Barrera Rodriguez, Aaron Alejandro ; Cheong, Soo Yeon ; Ghil, JeehoonRheumatology (Oxford, England), 2017-12, Vol.56 (12), p.2093-2101 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
|
7 |
Material Type: Artigo
|
Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studiesKimball, A.B. ; Papp, K.A. ; Reich, K. ; Gooderham, M. ; Li, Q. ; Cichanowitz, N. ; La Rosa, C. ; Blauvelt, A.British journal of dermatology (1951), 2020-06, Vol.182 (6), p.1359-1368 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
|
8 |
Material Type: Artigo
|
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritisVojinović, Jelena ; Foeldvari, Ivan ; Dehoorne, Joke ; Panaviene, Violeta ; Susic, Gordana ; Horneff, Gerd ; Stanevicha, Valda ; Kobusinska, Katarzyna ; Zuber, Zbigniew ; Dobrzyniecka, Bogna ; Akikusa, Jonathan ; Avcin, Tadej ; Borlenghi, Cecilia ; Arthur, Edmund ; Tatulych, Svitlana Y ; Zang, Chuanbo ; Tsekouras, Vassilis ; Vlahos, Bonnie ; Martini, Alberto ; Ruperto, NicolinoRheumatology (Oxford, England), 2024-01, Vol.63 (1), p.140-148 [Periódico revisado por pares]EnglandTexto completo disponível |
|
9 |
Material Type: Artigo
|
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registryGisondi, P. ; Bianchi, L. ; Calzavara‐Pinton, P. ; Conti, A. ; Chiricozzi, A. ; Fimiani, M. ; Pellegrino, M. ; Giunta, A. ; Prignano, F. ; Tiberio, R. ; Venturini, M. ; Girolomoni, G.British journal of dermatology (1951), 2019-02, Vol.180 (2), p.409-410 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
|
10 |
Material Type: Artigo
|
Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeksReich, K. ; Warren, R.B. ; Iversen, L. ; Puig, L. ; Pau‐Charles, I. ; Igarashi, A. ; Ohtsuki, M. ; Falqués, M. ; Harmut, M. ; Rozzo, S. ; Lebwohl, M.G. ; Cantrell, W. ; Blauvelt, A. ; Thaçi, D.British journal of dermatology (1951), 2020-03, Vol.182 (3), p.605-617 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |